Interestingly, a common variant of the LRP-6 co-receptor (Val-1062), which has reduced β-catenin signaling in vitro, was shown to interact with APO-ε4 carrier status to form a risk haplotype for AD [75]. This evidence concerns the gene AOPEP and Alzheimer disease.